WHO Pre-qualified

CE-Marked

Sensitivity: 100%

Specificity: 100%

Ultra Sensitive

INTENDED USE

The AQ+ COVID-19 Ag Rapid Test is a colloidal gold enhanced, rapid immunochromatographic assay for qualitative detection of SARS-CoV-2 antigens in the nasopharyngeal/ nasal specimen collected by swabs from individuals who are suspected of having COVID-19. The test is used as an aid in the diagnosis of SARS-CoV-2 infection. The test is suitable for use under healthcare professional supervision. Individuals should have appropriate training in how to administer the test correctly. Remote healthcare professional supervision can be used with appropriate clinical governance, once training has been completed and verified.

﹒Sensitivity: 93.64%

﹒Specificity: 100.00%

﹒Specimen: Nasal specimen

﹒ISO13485

CE –marked

﹒BfArM Test-ID: AT981/21

﹒Specimen: Nasopharyngeal/nasal specimen

﹒Sensitivity(NP): 96.3%

﹒Specificity(NP): 100%

﹒Sensitivity(N): 95.5%

﹒Specificity(N): 99.6%

INTENDED USE

The kit is intended to qualitatively detect Toxoplasma IgM, Toxoplasma IgG, Cytomegaloviru IgM, Cytomegaloviru IgG and Rubella virus IgG in human serum, plasma or whole blood in vitro. It is suitable for clinical auxiliary diagnosis of Toxoplasma infection, Cytomegalovirus infection and Rubella virus infection as well as their epidemiological inverstigation.

CE-marked

Sensitivity: 93.10%

Specificity: 100%

Specimen type: nasopharyngeal swabs

CE-marked

Sensitivity:

The Rapid Troponin l Test can detect cTnl in whole blood, serum or plasma with concentration of 0.5ng/ml or greater.

CE-marked

Specimen: whole blood, serum or plasma